Eli Lilly Stock in Focus After Slashing Cost of Popular Drug

Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound. The single-dose 2.5 and 5 milligram vials will be priced at $299 and $399, respectively, compared to previous prices of $349 and $499. The new pricing will be available on the company's direct-to-consumer platform LillyDirect.LLY is headed for its third-straight daily loss, extending a pullback from last week's record high ...